The exploration of glucocorticoid pathway based on disease severity in COVID-19 patients

The exploration of glucocorticoid pathway based on disease severity in COVID-19 patients

Systemic inflammation is a hallmark of Coronavirus Disease 2019 (COVID-19) and is the key to the pathophysiology of its severe cases with host cytokine involvement. Glucocorticoids can moderate this inflammatory effect due to receptor binding (NRC31-the gene encoded), influencing the expression of e...

Full description

Bibliographic Details
Main Authors: Gestina Aliska, Andani Eka Putra, Fenty Anggrainy, Mutia Lailani
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Heliyon
Subjects:
Cytokine
Coronavirus
Glucocorticoid-induced leucine zipper
Glucocorticoid receptor
Inflammation
Sequencing
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023107870

Internet

http://www.sciencedirect.com/science/article/pii/S2405844023107870

Similar Items